|Bid||6.55 x 0|
|Ask||6.57 x 0|
|Day's Range||6.46 - 6.60|
|52 Week Range||3.71 - 8.43|
|Beta (5Y Monthly)||1.67|
|PE Ratio (TTM)||2.13|
|Earnings Date||Aug 17, 2021 - Aug 23, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Sep 27, 2018|
|1y Target Est||10.50|
Nova Cannabis Inc. (the "Company" or "Nova") (TSXV: NOVC), is pleased to announce that it has received final approval for listing of the Company's common shares (the "Common Shares") on the Toronto Stock Exchange ("TSX").
EDMONTON, Alberta, June 30, 2021 (GLOBE NEWSWIRE) -- Alcanna Inc. (the "Company" or "Alcanna") (TSX: CLIQ) today reported it has received approval from the Toronto Stock Exchange (the "TSX") to commence a normal course issuer bid (the "NCIB"). The NCIB commences on July 5, 2021 and will terminate on the earlier of July 4, 2022 and the date on which the maximum number of common shares that can be acquired pursuant to the NCIB have been purchased. Under the NCIB, the Company is authorized to purch
Nova Cannabis Inc. (TSXV:NOVC, OTCQB:NVACF), today announced that Darren Karasiuk, CEO and David Gordey, CFO, will present live at VirtualInvestorConferences.com on June 30th.